Tyra Biosciences (TYRA) Stock: Buy, Sell, or Hold?
TYRA - Tyra Biosciences, Inc. Common Stock
$22.03
-1.51 (-6.41%)
▼
5d:
-11.38%
30d:
-12.92%
90d:
-13.84%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 8, 2026 at $26.73 · last confirmed Sep 11, 2026
Strength: 8.1/10
Get Alerted When TYRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TYRA is down 11.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TYRA is down 11.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TYRA is currently trading at $22.03, which is considered oversold relative to its 30-day fair value range of $23.88 to $28.18.
Technical Outlook: Technically, TYRA is in a strong downtrend. Immediate support is located at $18.66, while resistance sits at $29.56. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: TYRA scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $49.40 (+124.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TYRA is in a strong downtrend. Immediate support is located at $18.66, while resistance sits at $29.56. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: TYRA scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $49.40 (+124.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$23.88 -
$28.18
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.4%)
- BULLISH: Trading 124.2% below Wall St target ($49.40)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.88 -
$28.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.66
Resistance Level
$29.56
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.63
Wall Street Target
$49.40
(+124.2%)
Share & Embed Analysis
Last updated: September 12, 2026 3:20 AM ET
Data refreshes hourly during market hours. Next update: 4:20 AM
Data refreshes hourly during market hours. Next update: 4:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TYRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilla Kaplan
SELL
14295 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
|
LRMR
Larimar Therapeutics Inc |
STRONG BUY
11 analysts |
$14 | 58 HOLD |
